Wall Street Zen upgraded shares of Precision Optics (NASDAQ:POCI – Free Report) to a hold rating in a research note released on Saturday,Wall Street Zen reports.
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Precision Optics in a research report on Wednesday, September 2nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Precision Optics has an average rating of “Sell”.
Read Our Latest Report on POCI
Precision Optics Trading Up 4.4%
Precision Optics (NASDAQ:POCI – Get Free Report) last announced its quarterly earnings data on Monday, September 28th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.05. The firm had revenue of $8.77 million during the quarter, compared to analysts’ expectations of $7.10 million. Precision Optics had a negative return on equity of 23.92% and a negative net margin of 11.51%.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Precision Optics stock. Needham Investment Management LLC raised its position in shares of Precision Optics Corp. (NASDAQ:POCI – Free Report) by 2.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 720,000 shares of the company’s stock after purchasing an additional 20,000 shares during the period. Needham Investment Management LLC owned approximately 9.33% of Precision Optics worth $3,013,000 at the end of the most recent reporting period. 13.71% of the stock is owned by institutional investors.
About Precision Optics
Precision Optics Corporation, Inc (NASDAQ: POCI) designs and manufactures advanced optical and imaging systems, primarily for the medical device market. The company develops products used in minimally invasive surgery, including endoscopes, surgical cameras, and specialized visualization systems that help physicians view internal anatomy during diagnostic and therapeutic procedures.
Its product portfolio includes reusable and single-use endoscopes, three-dimensional imaging systems, fluorescence imaging technologies, and custom optical components and assemblies.
Recommended Stories
- Five stocks we like better than Precision Optics
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.
